Worth Venture Partners’s Imunon IMNN Stock Holding History

Worth Venture Partners’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-912	Closed	-$664K	–	128
2020 Q2	$664K	Buy	+912	New	+$395K	0.33%	45

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Worth Venture Partners's IMNN Position: Q3 2020 in Review

Worth Venture Partners sold out of Imunon (IMNN) in Q3 2020, closing a stake of 912 shares — an estimated $664K sold.

Worth Venture Partners first reported a position in IMNN in Q2 2020 and held it in 1 quarter. The position peaked at $664K in Q2 2020. 34 funds tracked by Wall St. Rank hold IMNN as of Q3 2020.

Worth Venture Partners reported no remaining Imunon position as of Q3 2020 after selling out during the quarter.
Worth Venture Partners sold 912 Imunon shares in Q3 2020, an estimated $664K.
Worth Venture Partners first reported a position in Imunon in Q2 2020 and held it in 1 quarter.
Worth Venture Partners's Imunon position peaked at $664K in Q2 2020.
34 funds tracked by Wall St. Rank held Imunon as of Q3 2020.

Based on Worth Venture Partners's 13F filing for Q3 2020, filed 16 Nov 2020.